CA1202616A - Sulfonate containing ester prodrugs of corticosteroids - Google Patents

Sulfonate containing ester prodrugs of corticosteroids

Info

Publication number
CA1202616A
CA1202616A CA000447557A CA447557A CA1202616A CA 1202616 A CA1202616 A CA 1202616A CA 000447557 A CA000447557 A CA 000447557A CA 447557 A CA447557 A CA 447557A CA 1202616 A CA1202616 A CA 1202616A
Authority
CA
Canada
Prior art keywords
general formula
compound
formula
compounds
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000447557A
Other languages
English (en)
French (fr)
Inventor
Bradley D. Anderson
Robert A. Conradi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of CA1202616A publication Critical patent/CA1202616A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000447557A 1983-03-30 1984-02-15 Sulfonate containing ester prodrugs of corticosteroids Expired CA1202616A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US480,603 1983-03-30
US06/480,603 US4469689A (en) 1983-03-30 1983-03-30 Sulfonate containing ester prodrugs of corticosteroids

Publications (1)

Publication Number Publication Date
CA1202616A true CA1202616A (en) 1986-04-01

Family

ID=23908597

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000447557A Expired CA1202616A (en) 1983-03-30 1984-02-15 Sulfonate containing ester prodrugs of corticosteroids

Country Status (6)

Country Link
US (1) US4469689A (cg-RX-API-DMAC10.html)
EP (1) EP0124233B1 (cg-RX-API-DMAC10.html)
JP (1) JPS59191000A (cg-RX-API-DMAC10.html)
CA (1) CA1202616A (cg-RX-API-DMAC10.html)
DE (1) DE3479891D1 (cg-RX-API-DMAC10.html)
ZA (1) ZA841455B (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
ES2041245T3 (es) * 1985-10-23 1993-11-16 The Upjohn Company Esteroides angioestaticos.
AU2138988A (en) * 1987-07-16 1989-02-13 Upjohn Company, The Amine salts of alkane-1,n-dicarboxylic acid mono- (2-sulfato-ethyl)amides
US5250711A (en) * 1987-07-16 1993-10-05 The Upjohn Company Amine salts of alkane-1,n-dicarboxylic acid mono-(2-sulfato-ethyl) amides
SK87295A3 (en) * 1993-01-08 1996-04-03 Astra Ab Novel colon or ileum-specific steroid derivatives
IT1293510B1 (it) * 1997-07-30 1999-03-01 Gentili Ist Spa Anticorpi monoclonali catalitici per la trasformazione in vivo di profarmaci di corticosteroidi
AU2173101A (en) * 1999-12-21 2001-07-03 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
KR100472303B1 (ko) * 2002-05-21 2005-03-08 김영미 결장표적성 프로드럭으로서의 코티코스테로이드21-설페이트 소듐 유도체
AU2003265576A1 (en) * 2002-08-23 2004-03-11 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
US20100047338A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
BRPI0908229A8 (pt) 2008-02-25 2017-10-10 Eyegate Pharma S A S Uso de um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste, kit e dispositivo para dispensar iontoforeticamente um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste no olho de um paciente para tratar um distúrbio ocular mediado por inflamação no referido paciente, e, formulação apropriada para dispensação iontoforética ocular de um corticosteróide, derivado de corticosteróide, pró-fármaco ou sal deste no olho de um paciente
CA2761389A1 (en) * 2009-02-05 2010-08-12 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
US9562015B2 (en) 2011-11-17 2017-02-07 The Regents Of The University Of Colorado, A Body Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
RU2617964C2 (ru) 2012-05-21 2017-04-28 Дзе Риджентс Оф Дзе Юниверсити Оф Колорадо, Э Боди Корпорэйт Пептиды ledgf и их композиции для лечения дегенеративных заболеваний
AU2014236135A1 (en) 2013-03-14 2015-09-10 Thomas Jefferson University Androgen receptor down-regulating agents and uses thereof
EP3033088A4 (en) 2013-08-12 2017-03-08 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
WO2019068726A1 (en) * 2017-10-02 2019-04-11 Scientist Of Fortune S.A. CELL TRANSPORT SYSTEM FOR TRANSFERRING CARGO SULFONIC ACID CONSTRUCTION IN CYTOPLASM OF CELL

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids
US2986559A (en) * 1959-01-07 1961-05-30 Schering Corp Novel therapeutic salts and processes for their manufacture
FR2408622A1 (fr) * 1977-05-06 1979-06-08 Roussel Uclaf Nouveaux derives du pregn 4-ene, leur procede de preparation et leur application comme medicament
SU818489A3 (ru) * 1978-10-04 1981-03-30 Шеринг Аг (Фирма) Способ получени кортикоид -21- СульфОпРОпиОНАТОВ или иХ СОлЕй

Also Published As

Publication number Publication date
EP0124233A2 (en) 1984-11-07
US4469689A (en) 1984-09-04
EP0124233B1 (en) 1989-09-27
JPH041760B2 (cg-RX-API-DMAC10.html) 1992-01-14
EP0124233A3 (en) 1985-01-16
JPS59191000A (ja) 1984-10-29
ZA841455B (en) 1984-10-31
DE3479891D1 (en) 1989-11-02

Similar Documents

Publication Publication Date Title
CA1202616A (en) Sulfonate containing ester prodrugs of corticosteroids
CA1199908A (en) Sulfonate prodrugs of corticosteroids
KR860000452B1 (ko) 소염작용을 갖는 연성 스테로이드의 제조방법
EP0208202B1 (en) 21-substituted thiosteroids
BG60799B2 (bg) Ароматни хетероциклени стероидни естери,получаването им и фармацевтични състави,които ги съдържат
CH638227A5 (fr) 17-butyrate 21-propionate d'hydrocortisone et composition anti-inflammatoire contenant ce compose.
HU186965B (en) Process for producing new 6-alpha-methyl-prednisolone derivatives
US5972922A (en) Steroids which inhibit angiogenesis
NZ199141A (en) 16,17-acetals of 16alpha-hydroxycortisol and pharmaceutical compositions
US4443440A (en) Amine containing ester prodrugs of corticosteroids
US4456602A (en) Amine containing ester prodrugs of corticosteroids
EP0332143B1 (en) 11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate]
US4567172A (en) 6α-Methylprednisolone derivatives
US4588718A (en) Carboxy containing ester prodrugs of corticosteroids
CA1251784A (en) Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments
US4933331A (en) Hydrocortisone 17-oxo-21-thioesters and their uses as medicaments
EP0193871A2 (en) 2-Oxa- or aza-pregnane compounds
JPH046200B2 (cg-RX-API-DMAC10.html)
JPS5817480B2 (ja) コルチコステロイド ２１− エステルユウドウタイノ セイゾウホウ
US3673179A (en) C-21 lower alkylsulfinyl esters of certain 21-hydroxycorticosteroids
JPH0615523B2 (ja) Ｓ−アルキルチオ−ｌ−システインスルフオキサイド化合物及びその製造方法並びにこれを含有する抗高脂血症及び強肝剤
HU187939B (en) Process for preparing new 6alpha-methyl-prednisolone derivatives
CS244662B2 (cs) Způsob výroby nových derivátů 9-chlorprednisolonu
JPS58103399A (ja) ６α−メチルプレドニゾロン１７−エステル化合物
EP0049783A1 (de) D-Homo-kortikoide, ihre Herstellung und Verwendung

Legal Events

Date Code Title Description
MKEX Expiry